+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Vaccine Contract Manufacturing Market Research Report by Function (Downstream and Upstream), by Type (Attenuated Vaccine, DNA Vaccines, Inactivated Vaccine, Subunit Vaccines, and Toxoid Vaccines), by Applications - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 4857952
  • Report
  • January 2021
  • Region: Global
  • 196 pages
  • 360iResearch™
UP TO OFF
until Jun 30th 2021
The Global Vaccine Contract Manufacturing Market to Grow USD 3,711.34 Million by 2025, at a CAGR of 11.90%

FEATURED COMPANIES

  • Ajinomoto Althea, Inc.
  • Cobra Bio
  • GlaxoSmithKline PLC
  • IDT Biologika
  • LONZA
  • Paragon Bioservices, Inc.
Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Vaccine Contract Manufacturing Market is expected to grow from USD 2,115.19 Million in 2020 to USD 3,711.34 Million by the end of 2025.
2. The Global Vaccine Contract Manufacturing Market is expected to grow from EUR 1,854.63 Million in 2020 to EUR 3,254.18 Million by the end of 2025.
3. The Global Vaccine Contract Manufacturing Market is expected to grow from GBP 1,648.77 Million in 2020 to GBP 2,892.97 Million by the end of 2025.
4. The Global Vaccine Contract Manufacturing Market is expected to grow from JPY 225,744.47 Million in 2020 to JPY 396,094.87 Million by the end of 2025.
5. The Global Vaccine Contract Manufacturing Market is expected to grow from AUD 3,071.53 Million in 2020 to AUD 5,389.37 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Vaccine Contract Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Function, the Vaccine Contract Manufacturing Market is examined across Downstream and Upstream. The Downstream further studied across Analytical & QC studies, Fill & Finish Operations, and Packaging. The Upstream further studied across Bacterial Expression Systems, Baculovirus/Insect Expression Systems, Mammalian Expression Systems, and Yeast Expression Systems.
  • Based on Type, the Vaccine Contract Manufacturing Market is examined across Attenuated Vaccine, DNA Vaccines, Inactivated Vaccine, Subunit Vaccines, and Toxoid Vaccines.
  • Based on Applications, the Vaccine Contract Manufacturing Market is examined across Human Use and Veterinary.
  • Based on Geography, the Vaccine Contract Manufacturing Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Vaccine Contract Manufacturing Market including Ajinomoto Althea, Inc., Albany Molecular Research, Inc., Catalent, Inc., Cobra Bio, Cytovance Biologics, FUJIFILM Diosynth Biotechnologies, GlaxoSmithKline PLC, ICON PLC, IDT Biologika, KBI Biopharma, LONZA, Merck KGaA, Paragon Bioservices, Inc., Pfizer, Inc., Pharmaceutical Product Development, LLC, and PRA Health Sciences.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. the ongoing research amplifies the research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Vaccine Contract Manufacturing Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Vaccine Contract Manufacturing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vaccine Contract Manufacturing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vaccine Contract Manufacturing Market?
4. What is the competitive strategic window for opportunities in the Global Vaccine Contract Manufacturing Market?
5. What are the technology trends and regulatory frameworks in the Global Vaccine Contract Manufacturing Market?
6. What are the modes and strategic moves considered suitable for entering the Global Vaccine Contract Manufacturing Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Ajinomoto Althea, Inc.
  • Cobra Bio
  • GlaxoSmithKline PLC
  • IDT Biologika
  • LONZA
  • Paragon Bioservices, Inc.
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Applications Outlook
3.4. Function Outlook
3.5. Type Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for vaccines leading to capacity expansion by contract manufacturers
5.1.1.2. Paradigm shift toward cell-based vaccine production
5.1.1.3. Key advantages such as cost and time saving offered by contract services
5.1.1.4. Vaccination coverage across the globe
5.1.2. Restraints
5.1.2.1. Limited outsourcing by well-established vaccine manufacturers
5.1.3. Opportunities
5.1.3.1. Rising global demand to cater to the growing population of varied age groups
5.1.3.2. Innovation and robust vaccine pipeline
5.1.3.3. Favorable government insights and guidelines to speed up the vaccine manufacturing
5.1.4. Challenges
5.1.4.1. Pharma companies manufacturing operations in-house to gain strategic control
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Global Vaccine Contract Manufacturing Market, By Function
6.1. Introduction
6.2. Downstream
6.2.1. Analytical & QC studies
6.2.2. Fill & Finish Operations
6.2.3. Packaging
6.3. Upstream
6.3.1. Bacterial Expression Systems
6.3.2. Baculovirus/Insect Expression Systems
6.3.3. Mammalian Expression Systems
6.3.4. Yeast Expression Systems

7. Global Vaccine Contract Manufacturing Market, By Type
7.1. Introduction
7.2. Attenuated Vaccine
7.3. DNA Vaccines
7.4. Inactivated Vaccine
7.5. Subunit Vaccines
7.6. Toxoid Vaccines

8. Global Vaccine Contract Manufacturing Market, By Applications
8.1. Introduction
8.2. Human Use
8.3. Veterinary

9. Americas Vaccine Contract Manufacturing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Vaccine Contract Manufacturing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand

11. Europe, Middle East & Africa Vaccine Contract Manufacturing Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Ajinomoto Althea, Inc.
13.2. Albany Molecular Research, Inc.
13.3. Catalent, Inc.
13.4. Cobra Bio
13.5. Cytovance Biologics
13.6. FUJIFILM Diosynth Biotechnologies
13.7. GlaxoSmithKline PLC
13.8. ICON PLC
13.9. IDT Biologika
13.10. KBI Biopharma
13.11. LONZA
13.12. Merck KGaA
13.13. Paragon Bioservices, Inc.
13.14. Pfizer, Inc.
13.15. Pharmaceutical Product Development, LLC
13.16. PRA Health Sciences

14. Appendix
14.1. Discussion Guide

List of Figures
Figure 1. Global Vaccine Contract Manufacturing Market: Research Process
Figure 2. Global Vaccine Contract Manufacturing Market: Research Execution
Figure 3. Global Vaccine Contract Manufacturing Market Size, 2020 Vs 2025 (USD Million)
Figure 4. Global Vaccine Contract Manufacturing Market Size, by Applications, 2020 (USD Million)
Figure 5. Global Vaccine Contract Manufacturing Market Size, by Function, 2020 (USD Million)
Figure 6. Global Vaccine Contract Manufacturing Market Size, by Type, 2020 (USD Million)
Figure 7. Global Vaccine Contract Manufacturing Market Size, by Geography, 2020 (USD Million)
Figure 8. Global Vaccine Contract Manufacturing Market Size, 2018-2025 (USD Million)
Figure 9. Global Vaccine Contract Manufacturing Market Size, by Geography, 2020 Vs 2025 (%)
Figure 10. Global Vaccine Contract Manufacturing Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 11. Competitive Strategic Window for Global Vaccine Contract Manufacturing Market Size, by Geography, 2025
Figure 12. Global Vaccine Contract Manufacturing Market: Market Dynamics
Figure 13. Global Vaccine Contract Manufacturing Market: Porters Five Forces Analysis
Figure 14. Global Vaccine Contract Manufacturing Market Size, by Function, 2020 Vs 2025 (%)
Figure 15. Global Vaccine Contract Manufacturing Market Size, by Function, 2020 Vs 2025 (USD Million)
Figure 16. Competitive Strategic Window for Global Vaccine Contract Manufacturing Market Size, by Function, 2025
Figure 17. Global Vaccine Contract Manufacturing Market Size, by Downstream, 2020 Vs 2025 (USD Million)
Figure 18. Global Vaccine Contract Manufacturing Market Size, by Analytical & Qc Studies, 2020 Vs 2025 (USD Million)
Figure 19. Global Vaccine Contract Manufacturing Market Size, by Fill & Finish Operations, 2020 Vs 2025 (USD Million)
Figure 20. Global Vaccine Contract Manufacturing Market Size, by Packaging, 2020 Vs 2025 (USD Million)
Figure 21. Global Vaccine Contract Manufacturing Market Size, by Upstream, 2020 Vs 2025 (USD Million)
Figure 22. Global Vaccine Contract Manufacturing Market Size, by Bacterial Expression Systems, 2020 Vs 2025 (USD Million)
Figure 23. Global Vaccine Contract Manufacturing Market Size, by Baculovirus/Insect Expression Systems, 2020 Vs 2025 (USD Million)
Figure 24. Global Vaccine Contract Manufacturing Market Size, by Mammalian Expression Systems, 2020 Vs 2025 (USD Million)
Figure 25. Global Vaccine Contract Manufacturing Market Size, by Yeast Expression Systems, 2020 Vs 2025 (USD Million)
Figure 26. Global Vaccine Contract Manufacturing Market Size, by Type, 2020 Vs 2025 (%)
Figure 27. Global Vaccine Contract Manufacturing Market Size, by Type, 2020 Vs 2025 (USD Million)
Figure 28. Competitive Strategic Window for Global Vaccine Contract Manufacturing Market Size, by Type, 2025
Figure 29. Global Vaccine Contract Manufacturing Market Size, by Attenuated Vaccine, 2020 Vs 2025 (USD Million)
Figure 30. Global Vaccine Contract Manufacturing Market Size, by Dna Vaccines, 2020 Vs 2025 (USD Million)
Figure 31. Global Vaccine Contract Manufacturing Market Size, by Inactivated Vaccine, 2020 Vs 2025 (USD Million)
Figure 32. Global Vaccine Contract Manufacturing Market Size, by Subunit Vaccines, 2020 Vs 2025 (USD Million)
Figure 33. Global Vaccine Contract Manufacturing Market Size, by Toxoid Vaccines, 2020 Vs 2025 (USD Million)
Figure 34. Global Vaccine Contract Manufacturing Market Size, by Applications, 2020 Vs 2025 (%)
Figure 35. Global Vaccine Contract Manufacturing Market Size, by Applications, 2020 Vs 2025 (USD Million)
Figure 36. Competitive Strategic Window for Global Vaccine Contract Manufacturing Market Size, by Applications, 2025
Figure 37. Global Vaccine Contract Manufacturing Market Size, by Human Use, 2020 Vs 2025 (USD Million)
Figure 38. Global Vaccine Contract Manufacturing Market Size, by Veterinary, 2020 Vs 2025 (USD Million)
Figure 39. Americas Vaccine Contract Manufacturing Market Size, by Geography, 2020 Vs 2025 (%)
Figure 40. Americas Vaccine Contract Manufacturing Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 41. Competitive Strategic Window for Americas Vaccine Contract Manufacturing Market Size, by Geography, 2025
Figure 42. Argentina Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 43. Brazil Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 44. Canada Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 45. Mexico Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 46. United States Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 47. Asia-Pacific Vaccine Contract Manufacturing Market Size, by Geography, 2020 Vs 2025 (%)
Figure 48. Asia-Pacific Vaccine Contract Manufacturing Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 49. Competitive Strategic Window for Asia-Pacific Vaccine Contract Manufacturing Market Size, by Geography, 2025
Figure 50. Australia Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 51. China Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 52. India Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 53. Indonesia Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 54. Japan Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 55. Malaysia Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 56. Philippines Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 57. South Korea Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 58. Thailand Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 59. Europe, Middle East & Africa Vaccine Contract Manufacturing Market Size, by Geography, 2020 Vs 2025 (%)
Figure 60. Europe, Middle East & Africa Vaccine Contract Manufacturing Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 61. Competitive Strategic Window for Europe, Middle East & Africa Vaccine Contract Manufacturing Market Size, by Geography, 2025
Figure 62. France Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 63. Germany Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 64. Italy Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 65. Netherlands Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 66. Qatar Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 67. Russia Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 68. Saudi Arabia Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 69. South Africa Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 70. Spain Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 71. United Arab Emirates Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 72. United Kingdom Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (USD Million)
Figure 73. Global Vaccine Contract Manufacturing Market: FPNV Positioning Matrix
Figure 74. Global Vaccine Contract Manufacturing Market: Market Share Analysis
Figure 75. Global Vaccine Contract Manufacturing Market: Competitor SWOT Analysis
Figure 76. Competitive Scenario Analysis in Global Vaccine Contract Manufacturing Market, by Type

List of Tables
Table 1. Currency Conversion Rates
Table 2. Global Vaccine Contract Manufacturing Market Size, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 3. Global Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 4. Global Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 5. Global Vaccine Contract Manufacturing Market Size, by Downstream, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 6. Global Vaccine Contract Manufacturing Market Size, by Analytical & Qc Studies, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 7. Global Vaccine Contract Manufacturing Market Size, by Fill & Finish Operations, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 8. Global Vaccine Contract Manufacturing Market Size, by Packaging, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 9. Global Vaccine Contract Manufacturing Market Size, by Upstream, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 10. Global Vaccine Contract Manufacturing Market Size, by Bacterial Expression Systems, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 11. Global Vaccine Contract Manufacturing Market Size, by Baculovirus/Insect Expression Systems, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 12. Global Vaccine Contract Manufacturing Market Size, by Mammalian Expression Systems, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 13. Global Vaccine Contract Manufacturing Market Size, by Yeast Expression Systems, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 14. Global Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 15. Global Vaccine Contract Manufacturing Market Size, by Attenuated Vaccine, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 16. Global Vaccine Contract Manufacturing Market Size, by Dna Vaccines, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 17. Global Vaccine Contract Manufacturing Market Size, by Inactivated Vaccine, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 18. Global Vaccine Contract Manufacturing Market Size, by Subunit Vaccines, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 19. Global Vaccine Contract Manufacturing Market Size, by Toxoid Vaccines, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 20. Global Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 21. Global Vaccine Contract Manufacturing Market Size, by Human Use, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 22. Global Vaccine Contract Manufacturing Market Size, by Veterinary, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 23. Americas Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 24. Americas Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 25. Americas Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 26. Americas Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 27. Argentina Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 28. Argentina Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 29. Argentina Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 30. Brazil Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 31. Brazil Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 32. Brazil Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 33. Canada Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 34. Canada Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 35. Canada Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 36. Mexico Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 37. Mexico Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 38. Mexico Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 39. United States Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 40. United States Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 41. United States Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 42. Asia-Pacific Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 43. Asia-Pacific Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 44. Asia-Pacific Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 45. Asia-Pacific Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 46. Australia Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 47. Australia Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 48. Australia Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 49. China Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 50. China Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 51. China Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 52. India Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 53. India Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 54. India Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 55. Indonesia Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 56. Indonesia Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 57. Indonesia Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 58. Japan Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 59. Japan Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 60. Japan Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 61. Malaysia Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 62. Malaysia Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 63. Malaysia Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 64. Philippines Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 65. Philippines Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 66. Philippines Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 67. South Korea Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 68. South Korea Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 69. South Korea Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 70. Thailand Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 71. Thailand Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 72. Thailand Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 73. Europe, Middle East & Africa Vaccine Contract Manufacturing Market Size, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 74. Europe, Middle East & Africa Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 75. Europe, Middle East & Africa Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 76. Europe, Middle East & Africa Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 77. France Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 78. France Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 79. France Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 80. Germany Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 81. Germany Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 82. Germany Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 83. Italy Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 84. Italy Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 85. Italy Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 86. Netherlands Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 87. Netherlands Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 88. Netherlands Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 89. Qatar Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 90. Qatar Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 91. Qatar Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 92. Russia Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 93. Russia Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 94. Russia Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 95. Saudi Arabia Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 96. Saudi Arabia Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 97. Saudi Arabia Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 98. South Africa Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 99. South Africa Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 100. South Africa Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 101. Spain Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 102. Spain Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 103. Spain Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 104. United Arab Emirates Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 105. United Arab Emirates Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 106. United Arab Emirates Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 107. United Kingdom Vaccine Contract Manufacturing Market Size, by Applications, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 108. United Kingdom Vaccine Contract Manufacturing Market Size, by Function, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 109. United Kingdom Vaccine Contract Manufacturing Market Size, by Type, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 110. Global Vaccine Contract Manufacturing Market: Scores
Table 111. Global Vaccine Contract Manufacturing Market: Business Strategy
Table 112. Global Vaccine Contract Manufacturing Market: Product Satisfaction
Table 113. Global Vaccine Contract Manufacturing Market: Ranking
Table 114. Global Vaccine Contract Manufacturing Market: Merger & Acquisition
Table 115. Global Vaccine Contract Manufacturing Market: Agreement, Collaboration, & Partnership
Table 116. Global Vaccine Contract Manufacturing Market: New Product Launch & Enhancement
Table 117. Global Vaccine Contract Manufacturing Market: Investment & Funding
Table 118. Global Vaccine Contract Manufacturing Market: Award, Recognition, & Expansion
Note: Product cover images may vary from those shown

Loading
LOADING...

  • Ajinomoto Althea, Inc.
  • Albany Molecular Research, Inc.
  • Catalent, Inc.
  • Cobra Bio
  • Cytovance Biologics
  • FUJIFILM Diosynth Biotechnologies
  • GlaxoSmithKline PLC
  • ICON PLC
  • IDT Biologika
  • KBI Biopharma
  • LONZA
  • Merck KGaA
  • Paragon Bioservices, Inc.
  • Pfizer, Inc.
  • Pharmaceutical Product Development, LLC
  • PRA Health Sciences
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll